SGEN — Seagen Share News
0.000.00%
Last trade - 00:00HealthcareBalancedLarge Cap
- $43.15bn
- $41.92bn
- $1.96bn
Brief: Seagen Says 6 Year Overall Survival Results Added To Us Prescribing Information For Adcetris As First-Line Treatment For Advanced Hodgkin Lymphoma
Brief: Seagen Says Pfizer Withdrew Its Notification And Report Form Filed With FTC And DOJ Relating To Merger Agreement And Will Refile That Form Today, June 14
Brief: Seagen Says Adcetris Plus Novel Immunotherapy Combination Delivers 98% Overall Response Rate And 93% Complete Response Rate In Patients With Early-Stage Classical Hodgkin Lymphoma
U.S. government sets penalties on 43 drugs over price hikes
Deals of the day-Mergers and acquisitions
Refinitiv Newscasts - U.S. Morning Call: Biden and McCarthy hopeful on debt ceiling deal
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Deals of the day-Mergers and acquisitions
Pfizer plans $31 bln debt offering to fund Seagen takeover (updated)
Brief: Pfizer Prices $31 Bln Debt Offering To Finance For Acquisition Of Seagen
Pfizer plans to raise $31 bln from debt offering to finance Seagen takeover
U.S. STOCKS ON THE MOVE-Applied Digital, Amdocs, First Watch
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
U.S. STOCKS ON THE MOVE-Shake Shack, Western Alliance, Blue Apron
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
U.S. STOCKS ON THE MOVE-Viking Therapeutics, Newell Brands, Seagen
FTC scrutiny to block Amgen-Horizon deal drags Seagen down
Brief: Pfizer Inc Said On May 12 Co, Seagen Filed Respective Report Forms Pursuant To Hart-Scott-Rodino Act With The Antitrust Division Of U.S DOJ & FTC
Pfizer CEO calls US drug price law 'negotiation with a gun to your head' (updated)